SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Israel-Rosen who wrote (574)4/8/1998 11:43:00 AM
From: yosi s  Read Replies (1) of 1491
 
Just to add on to PARS valuation

Neuroinvestor year end value PARS at 10$ but discounts it to 8 because of microcap.

Also it says HU211 is only one of many derivatives, that PARS works on.
Again the big future for PARS will come from HU211,
HU211 is promising because of expected mortality is 18-24% in the study. and 30% otherwise . the actual mortality observed is 12%
In order for that to occur 5% mortality (or about) is deducted to occur in HU211 arm. THIS IS BIG news if shown to be true once the code is open.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News